Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Inflammation, hypertension, and the metabolic syndrome.

Grundy SM.

JAMA. 2003 Dec 10;290(22):3000-2. No abstract available.

PMID:
14665663
2.

Statin therapy in metabolic syndrome and hypertension post-JUPITER: what is the value of CRP?

Devaraj S, Siegel D, Jialal I.

Curr Atheroscler Rep. 2011 Feb;13(1):31-42. doi: 10.1007/s11883-010-0143-2. Review.

3.

C-reactive protein, inflammation, and cardiovascular disease: clinical update.

Ridker PM.

Tex Heart Inst J. 2005;32(3):384-6. Review. No abstract available.

4.

Role of C-reactive protein in contributing to increased cardiovascular risk in metabolic syndrome.

Devaraj S, Valleggi S, Siegel D, Jialal I.

Curr Atheroscler Rep. 2010 Mar;12(2):110-8. doi: 10.1007/s11883-010-0098-3. Review.

5.

The use of high-sensitivity assays for C-reactive protein in clinical practice.

Musunuru K, Kral BG, Blumenthal RS, Fuster V, Campbell CY, Gluckman TJ, Lange RA, Topol EJ, Willerson JT, Desai MY, Davidson MH, Mora S.

Nat Clin Pract Cardiovasc Med. 2008 Oct;5(10):621-35. doi: 10.1038/ncpcardio1322. Epub 2008 Aug 19. Review.

6.

The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease.

Haffner SM.

Am J Cardiol. 2006 Jan 16;97(2A):3A-11A. Epub 2005 Dec 5. Review.

PMID:
16442931
7.

[Inflammation biomarkers capacity in predicting the metabolic syndrome].

Volp AC, Alfenas Rde C, Costa NM, Minim VP, Stringueta PC, Bressan J.

Arq Bras Endocrinol Metabol. 2008 Apr;52(3):537-49. Review. Portuguese.

8.

Effects of different dietary approaches on inflammatory markers in patients with metabolic syndrome: A systematic review and meta-analysis.

Steckhan N, Hohmann CD, Kessler C, Dobos G, Michalsen A, Cramer H.

Nutrition. 2016 Mar;32(3):338-48. doi: 10.1016/j.nut.2015.09.010. Epub 2015 Oct 28. Review.

PMID:
26706026

Supplemental Content

Support Center